Global Animal Biotechnology Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Animal Biotechnology Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application
Animal biotechnology refers to the branch of biotechnology, which deals with the molecular biology techniques for producing genetically engineered animals (whose genome are modified), in order to make them suitable for pharmaceutical, industrial or agricultural applications. The genetically modified animals have improved growth rates, synthesized therapeutic proteins, and are resistant to various diseases. Increasing R&D by the major market players, rising regulatory approvals, and the rising focus toward cloning and transgenic animals are contributing to the market growth. However, high cost of research and development, and the ethical issues associated with animal biotechnology products may adversely affect the market growth.
Animal Biotechnology report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Animal Biotechnology market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Preventive Care for Animals and Development of Animal Pharmaceuticals are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Animal Biotechnology industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Animal Biotechnology key companies include Bayer AG, Merck &, Inc., Pfizer, Inc., Sanofi, Biogenesis Bago, Santa Cruz Biotechnology, Inc., Boehringer Inghlem, Virbac Inc. and Zoetis, etc. Bayer AG, Merck &, Inc., Pfizer, Inc. are top 3 players and held % share in total in 2022.
Animal Biotechnology can be divided into Diagnostic Tests, Drugs, Reporductive & Genetic Produtcs and Vaccines, etc. Diagnostic Tests is the mainstream product in the market, accounting for % share globally in 2022.
Animal Biotechnology is widely used in various fields, such as Preventive Care for Animals, Development of Animal Pharmaceuticals, Food Safety and Drug Development and Others, etc. Preventive Care for Animals provides greatest supports to the Animal Biotechnology industry development. In 2022, global % share of Animal Biotechnology went into Preventive Care for Animals filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Animal Biotechnology market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
Bayer AG
Merck &, Inc.
Pfizer, Inc.
Sanofi
Biogenesis Bago
Santa Cruz Biotechnology, Inc.
Boehringer Inghlem
Virbac Inc.
Zoetis
Segment by Type
Diagnostic Tests
Drugs
Reporductive & Genetic Produtcs
Vaccines
Preventive Care for Animals
Development of Animal Pharmaceuticals
Food Safety and Drug Development
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Animal Biotechnology market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2024, 2024-2034).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Animal Biotechnology introduction, etc. Animal Biotechnology Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12QYResearch’s Conclusions of Animal Biotechnology market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by QYResearch.
Animal Biotechnology report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Animal Biotechnology market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Preventive Care for Animals and Development of Animal Pharmaceuticals are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Animal Biotechnology industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Animal Biotechnology key companies include Bayer AG, Merck &, Inc., Pfizer, Inc., Sanofi, Biogenesis Bago, Santa Cruz Biotechnology, Inc., Boehringer Inghlem, Virbac Inc. and Zoetis, etc. Bayer AG, Merck &, Inc., Pfizer, Inc. are top 3 players and held % share in total in 2022.
Animal Biotechnology can be divided into Diagnostic Tests, Drugs, Reporductive & Genetic Produtcs and Vaccines, etc. Diagnostic Tests is the mainstream product in the market, accounting for % share globally in 2022.
Animal Biotechnology is widely used in various fields, such as Preventive Care for Animals, Development of Animal Pharmaceuticals, Food Safety and Drug Development and Others, etc. Preventive Care for Animals provides greatest supports to the Animal Biotechnology industry development. In 2022, global % share of Animal Biotechnology went into Preventive Care for Animals filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Animal Biotechnology market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
By Company
Bayer AG
Merck &, Inc.
Pfizer, Inc.
Sanofi
Biogenesis Bago
Santa Cruz Biotechnology, Inc.
Boehringer Inghlem
Virbac Inc.
Zoetis
Segment by Type
Diagnostic Tests
Drugs
Reporductive & Genetic Produtcs
Vaccines
Segment by Application
Preventive Care for Animals
Development of Animal Pharmaceuticals
Food Safety and Drug Development
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Animal Biotechnology market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2024, 2024-2034).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Animal Biotechnology introduction, etc. Animal Biotechnology Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12QYResearch’s Conclusions of Animal Biotechnology market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by QYResearch.